Why Treg Apheresis First: The Foundation of Real Healing in Chronic Lyme

If you've tried antibiotics, herbals, and detox protocols without lasting results, this is why — and what the missing piece actually is.

There's a question every chronic Lyme patient eventually asks, usually after years of partial improvements and disappointing relapses: why isn't this working?

The frustrating answer is that most chronic Lyme treatment is aimed at the wrong target. Antibiotics, antimicrobials, even many integrative protocols — they're all chasing symptoms downstream. They're trying to eliminate bacteria while ignoring the fundamental reason the body can't resolve the infection on its own: the immune system has lost its ability to regulate itself.

That's not a metaphor. It is a specific, documented biological failure. And it has a name: Treg depletion.

Your Immune System's Thermostat

T-regulatory cells — Tregs — are the immune system's thermostat. Their job is to tell inflammation when to stop. They prevent your immune response from attacking healthy tissue after a threat has been addressed. They maintain the balance that allows your body to fight infections hard, and then stand down when the work is done.

When Borrelia burgdorferi persists in the body, Treg function becomes depleted and dysregulated. The result is an immune system stuck in perpetual activation — generating inflammation, fatigue, neurological symptoms, and autoimmune-like flares long after the initial infection. Research from Harvard Medical School and Massachusetts General Hospital confirmed this directly: in patients with antibiotic-refractory Lyme arthritis, lower Treg counts in the synovial fluid correlated directly with worse outcomes — longer duration of arthritis, less response to treatment, and in many cases, the need for surgical intervention. Based on articles retrieved from PubMed: DOI: 10.1002/art.27468

Why Killing Pathogens Isn't Enough

This is the part that most Lyme treatment misses entirely. If your immune system can't regulate itself, eliminating bacteria doesn't restore health. The body keeps overreacting. Keeps inflaming. Keeps misfiring. This is why so many patients improve briefly on antibiotics — then crash again as soon as treatment stops.

The bacteria may be reduced. But the regulatory architecture that was supposed to end the immune response was never rebuilt. So the war continues.

What Treg Apheresis Does

Treg apheresis is not a drug. It is not an immunosuppressant. It is a recalibration of the patient's own immune intelligence.

The process involves working with the body's existing regulatory T-cell population — isolating, supporting, and reintroducing Tregs so the immune system can finally do what it was designed to do: modulate its own response, resolve inflammation, and stop the internal war that has been running unchecked.

The UCSF TILT trial — published in JCI Insight — demonstrated that Treg infusion combined with low-dose IL-2 successfully expanded Treg populations and improved immune regulation across all patients in the study, with an excellent safety profile. Based on articles retrieved from PubMed: DOI: 10.1172/jci.insight.147474

Why "First" Matters

When you restore immune regulation before adding other interventions, everything that comes after works better. The body can finally respond appropriately. Other therapies — whether nutritional, physical, or pharmacological — land on a system that can actually use them.

This is why Treg apheresis is the starting point of the Lyme Re-code program at the Immunotherapy Institute. Not because it's the simplest option. Because it's the foundational one. You don't renovate the floors before fixing the foundation. You don't add therapies to an immune system that still can't regulate itself and expect lasting results.

The Lyme Re-code 10-Day Program

The entry point for most patients is the 10-day Treg apheresis program — a focused, foundational protocol that gives the immune system what it most urgently needs: its regulatory capacity back. The program includes a buffer day after the final treatment for monitoring and discharge consultation before patients travel home.

Patients who later want to go deeper can progress into the 18-day program, which layers in systemic hyperthermia and a second round of apheresis — on a body that has already begun to recalibrate. That's a very different starting point than going in without the foundation.

What patients typically experience from the 10-day: reduced inflammatory symptoms, improved energy, better neurological clarity, more stable mood, and — most importantly — an immune system that is finally responding the way it's supposed to.

This isn't a cure. It's a foundation. And foundations are where real recovery becomes possible.